{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-10-20&answer.questionFirstAnswered.=2014-10-27T17%3A11%3A03.5550551Z&answer.dateOfAnswer=2014-10-27&min-answer.questionFirstAnswered.=2014-10-27T16%3A43%3A52.2085406Z&answeringDeptSortName=Health", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?date=2014-10-20&answer.questionFirstAnswered.=2014-10-27T17%3A11%3A03.5550551Z&answer.dateOfAnswer=2014-10-27&min-answer.questionFirstAnswered.=2014-10-27T16%3A43%3A52.2085406Z&answeringDeptSortName=Health", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-10-20&answer.questionFirstAnswered.=2014-10-27T17%3A11%3A03.5550551Z&answer.dateOfAnswer=2014-10-27&min-answer.questionFirstAnswered.=2014-10-27T16%3A43%3A52.2085406Z&answeringDeptSortName=Health&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-10-20&answer.questionFirstAnswered.=2014-10-27T17%3A11%3A03.5550551Z&_page=0&answer.dateOfAnswer=2014-10-27&min-answer.questionFirstAnswered.=2014-10-27T16%3A43%3A52.2085406Z&answeringDeptSortName=Health", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-10-20&answer.questionFirstAnswered.=2014-10-27T17%3A11%3A03.5550551Z&answer.dateOfAnswer=2014-10-27&min-answer.questionFirstAnswered.=2014-10-27T16%3A43%3A52.2085406Z&answeringDeptSortName=Health", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?date=2014-10-20&answer.questionFirstAnswered.=2014-10-27T17%3A11%3A03.5550551Z&answer.dateOfAnswer=2014-10-27&min-answer.questionFirstAnswered.=2014-10-27T16%3A43%3A52.2085406Z&answeringDeptSortName=Health", "items" : [{"_about" : "http://data.parliament.uk/resources/99861", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/99861/answer", "answerText" : {"_value" : "
The decision that there should be a two-stage ex-gratia payment system was taken when the scheme was first established in 2003-04. An initial \u2018stage 1\u2019 lump sum payment was made in respect of chronic infection with hepatitis C, with a second \u2018stage 2\u2019 lump sum payment when people reached a more advanced stage of illness. The Department sought the advice of an independent group of experts regarding a medical trigger for the higher payment that could reliably be diagnosed with non-invasive tests that were available nationwide. The advice received was that the second lump sum payment should be triggered following a diagnosis of cirrhosis or liver cancer, or if a person had received a liver transplant.<\/p>
<\/p>
<\/p>
<\/p>
In addition, as a result of the 2010 expert review, a further condition was added to those conditions that triggered eligibility for the second stage payment, namely hepatitis C-associated B-cell non-Hodgkins Lymphoma.<\/p>
<\/p>
<\/p>
<\/p>
<\/strong><\/p> <\/p> <\/strong><\/p> <\/p> <\/strong><\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/3918", "label" : {"_value" : "Biography information for Jane Ellison"}
}
, "answeringMemberConstituency" : {"_value" : "Battersea"}
, "answeringMemberPrinted" : {"_value" : "Jane Ellison"}
, "dateOfAnswer" : {"_value" : "2014-10-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2014-10-27T17:11:03.5550551Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2014-10-20", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Hepatitis"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health, what the basis is for the distinction between Stage 1 and Stage 2 of hepatitis C virus which determines the amount of support sufferers of the condition who contracted the virus following NHS treatment with blood products are entitled to; and what medical and expert advice his Department sought before establishing this distinction.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1533", "label" : {"_value" : "Biography information for Dame Diana Johnson"}
}
, "tablingMemberConstituency" : {"_value" : "Kingston upon Hull North"}
, "tablingMemberPrinted" : [{"_value" : "Diana Johnson"}
], "uin" : "211083"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 1, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}